Eastern Journal of Psychiatry

Register      Login

VOLUME 24 , ISSUE 1 ( January-June, 2024 ) > List of Articles

Original Article

Neuropsychological Functioning in Patients with Opioids Dependence during Early Abstinence: A Comparative Study

S TM Muhammed, Neha Sayeed, Vikas Kumar

Keywords : Opioid dependence, Perceptual reasoning, Processing speed, Verbal comprehension, Working memory

Citation Information : Muhammed ST, Sayeed N, Kumar V. Neuropsychological Functioning in Patients with Opioids Dependence during Early Abstinence: A Comparative Study. 2024; 24 (1):9-15.

DOI: 10.5005/jp-journals-11001-0074

License: CC BY-NC 4.0

Published Online: 08-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Background: People with opioid dependence have various effects, especially in the areas of psychological, physiological, and social functioning. Aim: To study the improvement in neuropsychological functioning of patients with opioid dependence during early abstinence. Materials and methods: The study focused on 15 patients with chronic and acute opioid dependence each. Samples were taken after the detoxification period of 2 weeks. The clinical opiate withdrawal scale (COWS) was applied to rule out mild-to-severe withdrawal symptoms, and the severity dependence scale was applied to determine the severity of opioid dependence. Wechsler Adult Intelligence Scale (WAIS)-IV India was administered twice to both groups, just after the detoxification period and at the time of discharge. Results and discussion: The result indicates that both groups showed a significant difference in neuropsychological functioning from baseline to discharge. Scores on verbal comprehension, perceptual reasoning, working memory, processing speed, and intellectual functioning among acute opioid users improved significantly from baseline to discharge, whereas the chronic users showed a decrease in their perceptual reasoning over time. Conclusion: Acute opioid users showed significant improvement in neuropsychological functioning over time, whereas chronic users took time to recover their neuropsychological functioning.

PDF Share
  1. Volkow ND, Li TK. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Therapeut 2005;108(1):3–17. DOI: 10.1016/j.pharmthera.2005.06.021
  2. Leshner AI. Addiction is a brain disease, and it matters. Science 1997;278(5335):45–47. DOI: 10.1126/science.278.5335.45
  3. Ersche KD, Clark L, London M, et al. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacol 2006;31(5):1036–1047. DOI: 10.1038/sj.npp.1300889
  4. Zacny JP. A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995;3(4):432–466. DOI: 10.1037/1064-1297.3.4.432
  5. Grant I, Adams KM, Carlin AS, et al. Neuropsychological deficit in polydrug users: a preliminary report of the findings of the Collaborative Neuropsychological Study of polydrug users. Drug Alcohol Depend 1977;2(2):91–108. DOI: 10.1016/0376-8716(77)90010-2
  6. Rapeli P, Kivisaari R, Autti T, et al. Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry 2006;6(1):9. DOI: 10.1186/1471-244X-6-9
  7. Turner TH, LaRowe S, Horner MD, et al. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat 2009;37(4):328–334. DOI: 10.1016/j.jsat.2009.03.009
  8. Guerra D, Solé A, Camí J, et al. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend 1987;20(3):261–270. DOI: 10.1016/0376-8716(87)90036-6
  9. Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend 2002;67(1):105–108. DOI: 10.1016/s0376-8716(02)00012-1
  10. Aharonovich E, Nunes E, Hasin D. Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend 2003;71(2):207–211. DOI: 10.1016/s0376-8716(03)00092-9
  11. Gossop M, Stewart D, Browne N, et al. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 2002;97(10):1259–1267. DOI: 10.1046/j.1360-0443.2002.00227.x
  12. Ornstein TJ, Iddon JL, Baldacchino AM, et al. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000;23(2):113–126. DOI: 10.1016/S0893-133X(00)00097-X
  13. Vo HT, Schacht R, Mintzer M, et al. Working memory impairment in cannabis-and opioid-dependent adolescents. Substance Abuse 2014;35(4):387–390. DOI: 10.1080/08897077.2014.954027
  14. Roohi NN, Hamidi F, Farahani KS. Cognitive consequences of drug abuser: comparison with abuse of stimulants and opioid with regard to attention and working memory. Procedia Soc Behav Sci 2010;5:1698–1701. DOI: 10.22122/ahj.v14i1.292
  15. Davis DD, Templer DI. Neurobehavioral functioning in children exposed to narcotics in utero. Addict Behav 1988;13(3):275–283. DOI: 10.1016/0306-4603(88)90054-8
  16. Pope Jr HG, Gruber AJ, Hudson JI, et al. Cognitive measures in long-term cannabis users. J Clin Pharmacol 2002;42(S1):41S–47S. DOI: 10.1002/j.1552-4604.2002.tb06002.x
  17. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002;67(1):41–51. DOI: 10.1016/s0376-8716(02)00013-3
  18. Schulte MH, Cousijn J, den Uyl TE, et al. Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clin Psychol Rev 2014;34(7):531–550. DOI: 10.1016/j.cpr.2014.08.002
  19. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva. World Health Organization 1993.
  20. Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoact Drug 2003;35(2):253–259. DOI: 10.1080/02791072.2003.10400007
  21. Wechsler D. Wechsler adult intelligence scale.
  22. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bullet 1997;121(1):65–94. DOI: 10.1037/0033-2909.121.1.65
  23. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatr 1996;37(1):51–87. DOI: 10.1111/j.1469-7610.1996.tb01380.x
  24. Gruber SA, Silveri MM, Yurgelun-Todd DA. Neuropsychological consequences of opiate use. Neuropsychol Rev 2007;17(3):299–315. DOI: 10.1007/s11065-007-9041-y
  25. Yan WS, Li YH, Xiao L, et al. Working memory and affective decision-making in addiction: a neurocognitive comparison between heroin addicts, pathological gamblers and healthy controls. Drug Alcohol Depend 2014;134:194–200. DOI: 10.1016/j.drugalcdep.2013.09.027
  26. Alhola P, Polo-Kantola P. Sleep deprivation: impact on cognitive performance. Neuropsychiatr Dis Treat 2007;3(5):553–567. PMID: 19300585.
  27. Janke van Holst R, Schilt T. Drug-related decrease in neuropsychological functions of abstinent drug users. Curr Drug Abuse Rev 2011;4(1):42–56. DOI: 10.2174/1874473711104010042
  28. Pau CW, Lee TM, Chan SF. The impact of heroin on frontal executive functions. Arch Clin Neuropsychol 2002;17(7):663–670. PMID: 14591849.
  29. Brown RR, Partington JE. Short articles and notes: the intelligence of the narcotic drug addict. J Gen Psychol 1942;26(1):175–179. Available from: https://psycnet.apa.org/fulltext/2008-18545-000-BKM.pdf
  30. Hill SY, Mikhael MA. Computerized transaxial tomographic and neuropsychological evaluations in chronic alcoholics and heroin abusers. Am J Psychiatry 1979;136(4B):598–602. DOI: 10.1176/ajp.1979.136.4b.598
  31. Rogers RD, Robbins TW. Investigating the neurocognitive deficits associated with chronic drug misuse. Curr Opin Neurobiol 2001;11(2):250–257. DOI: 10.1016/s0959-4388(00)00204-x
  32. Franken IH, Kroon LY, Wiers RW, et al. Selective cognitive processing of drug cues in heroin dependence. J Psychopharmacol 2000;14(4):395–400. DOI: 10.1177/026988110001400408
  33. Kar SK, Jain M. Current understandings about cognition and the neurobiological correlates in schizophrenia. J Neurosci Rural Pract 2016;7(3):412–418. DOI: 10.4103/0976-3147.176185
  34. Fernandez-Serrano MJ, Pérez-García M, Verdejo-García A. What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neurosci Biobehav Rev 2011;35(3):377–406. DOI: 10.1016/j.neubiorev.2010.04.008
  35. Singer LT, Minnes S, Short E, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. Jama 2004;291(20):2448–2456. DOI: 10.1001/jama.291.20.2448
  36. Singer LT, Nelson S, Short E, et al. Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 2008;153(1):105–111. DOI: 10.1016/j.jpeds.2008.01.001
  37. Strang J, Gurling H. Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. Br J Addict 1989;84(9):1011–1019. DOI: 10.1111/j.1360-0443.1989.tb00784.x
  38. De Arcos FA, Verdejo-García A, Ceverino A, et al. Dysregulation of emotional response in current and abstinent heroin users: negative heightening and positive blunting. Psychopharmacology 2008;198(2):159–166. DOI: 10.1007/s00213-008-1110-2
  39. Fishbein DH, Krupitsky E, Flannery BA, et al. Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use. Drug Alcohol Depend 2007;90(1):25–38. DOI: 10.1016/j.drugalcdep.2007.02.015
  40. Isbell H, Wilker A, Eisenman AJ, et al. Liability of addiction to 6-dimethylamino-4-4-diphenyl-3-heptanone (methadon, amidone or 10820) in man: experimental addiction to methadon. Arch Int Med 1948;82(4):362–392. DOI: 10.1001/archinte.1948.00020040042004
  41. Gordon NB, Lipset J. Intellectual and functional status after almost ten years of methadone maintenance treatment. Presentation—American Psychological Association Convention. 1976.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.